KEMRI-Wellcome Trust Collaborative Research Program: Clinical Trials

37 trials sponsored by KEMRI-Wellcome Trust Collaborative Research Program, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 13 unknown, 2 recruiting, 1 active not recruiting. 9 Phase 1, 8 Phase 2, 7 Not applicable, 7 Phase 3, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 19Completed 5, Unknown 2, Recruiting 1, Suspended 1
Phase 28Completed 5, Unknown 2, Suspended 1
Not applicable7Completed 4, Unknown 2, Not yet recruiting 1
Phase 37Completed 4, Unknown 2, Active not recruiting 1
Phase 44Completed 2, Unknown 2

Follow KEMRI-Wellcome Trust Collaborative Research Program: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Start Taking Action for Tuberculosis in Kids
Xpert MTB/RIF Ultra, Truenat, MTB, Truenat MTB Plus - TB - Tuberculosis
Not applicableNot yet recruitingLiverpool School of Tropical Medicine79202026-03-012025-11-25
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Shigella sonnei 53G, Ciprofloxacin 500 mg - Shigellosis
Phase 1RecruitingUniversity of Oxford702025-01-212025-03-13
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Rifampicin, Azithromycin, Isoniazid - Severe Acute Malnutrition, HIV
Phase 3CompletedQueen Mary University of London6742024-07-152026-08-25
Social Media as a Risk Tool for HIV Prevention Needs
HIV Prevention, HIV Preexposure Prophylaxis
CompletedMassachusetts General Hospital4002024-02-012026-08-31
Controlled Human Malaria Infection Transmission Model - Phase A
PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine - Malaria,Falciparum
Phase 1 / Phase 2SuspendedUniversity of Oxford442022-08-222024-05-23
Transcriptomic Responses for the Identification of Pathogens
5-gene transcription signature - Enteric Fever, Acute Febrile Illness
RecruitingUniversity of Sheffield20002022-05-022025-03-03
Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications
Mobile phone message reminders. - Epilepsy, Treatment Adherence
Not applicableUnknownKEMRI-Wellcome Trust Collaborative Research Program12002022-05-012022-04-11
A Study to Test Three Experimental HIV Vaccines in Healthy Adults.
Vaccine, Placebo - HIV-1-infection
Phase 1UnknownUniversity of Oxford882021-08-162022-06-22
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
Pancreatic Enzyme, Ursodeoxycholic acid, Pancreatic Enzyme placebo - SEPSIS, MALNUTRITION, CHILD
Phase 2 / Phase 3UnknownUniversity of Oxford4002021-07-012023-02-24
Gonococcal Vaccine Study in Key Populations in Kenya
4CMenB (Bexsero®) vaccine - Gonorrhea
Not applicableCompletedUniversity of Oxford502021-05-312022-04-14
R21/Matrix-M in African Children Against Clinical Malaria
R21/Matrix-M, Rabies vaccine, Hepatitis A vaccine or Meningococcal vaccine - Malaria
Phase 3Active not recruitingUniversity of Oxford48002021-04-292026-02-23
Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya
Artemether + Lumefantrine, Dihydroartemisin-piperaquine, Artesunate-Amodiaquine (AS-AQ) - Malaria Falciparum
CompletedStrathmore University3162020-06-012026-01-23
Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)
Intermittent Preventive Therapy with Dihydroartemisinin-Piperaquine - Pregnancy; HIV; Malaria
Phase 3CompletedLiverpool School of Tropical Medicine8982019-11-112023-08-22
Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine
Yellow fever vaccine, Institut Pasteur - Yellow Fever
Phase 4CompletedUniversity of Oxford9002019-11-112024-02-09
A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants
Shigella 4V, MenACWY, Rabies - Shigellosis
Phase 1 / Phase 2CompletedLimmaTech Biologics AG5972019-09-022026-06-23
Malaria Birth Cohort (MBC) in Agogo, Ghana
Malaria
UnknownBernhard Nocht Institute for Tropical Medicine18002019-04-082021-09-01
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants
PCV10, PCV13 - Pneumococcal Infection, Streptococcus Pneumoniae Infection
Phase 4CompletedLondon School of Hygiene and Tropical Medicine21002019-03-212024-11-12
Passive Dietary Intake Assessment Study
Passive Dietary Monitoring - Dietary Intake Assessment, Passive Dietary Monitoring
UnknownImperial College London2642018-11-152024-03-19
Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis
Standard of Care + Fosfomycin, PK, Analysis of Bacterial Isolates - Neonatal SEPSIS
Phase 2CompletedDrugs for Neglected Diseases1202018-03-152020-02-17
First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition
Ceftriaxone, Benzyl penicillin, Metronidazole - Malnutrition Severe, Antibiotic Resistance
Phase 3UnknownUniversity of Oxford20002017-09-042020-05-19

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Malaria (10)  ·  Malnutrition (6)  ·  Pneumonia (3)  ·  Severe Acute Malnutrition (3)  ·  Child Nutrition Disorders (2)  ·  Diarrhea (2)  ·  Dysentery, Bacillary (2)  ·  Malaria, Falciparum (2)  ·  Pneumonia, Pneumococcal (2)  ·  Sepsis (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Adenoviridae Infections (1)  ·  Bacteremia (1)  ·  Cachexia (1)  ·  Disease (1)

Interventions

10-valent pneumococcal conjugate vaccine (2)  ·  Artemether, Lumefantrine Drug Combination (2)  ·  Ceftriaxone (2)  ·  Hepatitis A Vaccines (2)  ·  Metronidazole (2)  ·  PHiD-CV vaccine (2)  ·  Penicillin G (2)  ·  Standard of Care (2)  ·  Vaccines (2)  ·  13-valent pneumococcal vaccine (1)  ·  4CMenB vaccine (1)  ·  Amoxicillin (1)  ·  Artesunate (1)  ·  Azithromycin (1)  ·  Child Development (1)

Countries

Kenya (29)  ·  Uganda (5)  ·  Malawi (3)  ·  Bangladesh (2)  ·  United Kingdom (2)  ·  Zambia (2)  ·  Germany (1)  ·  Ghana (1)  ·  India (1)  ·  Pakistan (1)  ·  Switzerland (1)  ·  Tanzania (1)  ·  Zimbabwe (1)

Top investigators

Mike English, MD (2)  ·  Adrian VS Hill, PhD (1)  ·  Alexandre Macedo De Oliveira, MD (1)  ·  Alexis Nzila, Msc (1)  ·  Ally Olotu (1)  ·  Ambrose Agweyu, MSc (1)  ·  Anthony Scott, MD, PhD (1)  ·  Arjune Sen, PhD (1)  ·  Charles R Newton, MD (1)  ·  Claire-Anne Siegrist, MD (1)  ·  Don de Savigny, PhD (1)  ·  Eduard Sanders, MD (1)  ·  Eduard Sanders, MD, PhD (1)  ·  Elizabeth Obimbo, MMed (1)  ·  Eva Mertens, PhD (1)

Results publications

PMID 25830326, PMID 26659569, PMID 28647166, PMID 21410944, PMID 23514288, PMID 24465570, PMID 25550349, PMID 25902844, PMID 26083474, PMID 26248510, PMID 27077745, PMID 27355532, PMID 28434944, PMID 28877729, PMID 29627147, PMID 30452666, PMID 30807589, PMID 30832678, PMID 31061058, PMID 31775877, PMID 31803847, PMID 31984244, PMID 32099953, PMID 33154417, PMID 33855449, PMID 34264864, PMID 34538239, PMID 35073864, PMID 35078765, PMID 35107141, PMID 35835738, PMID 36123771, PMID 36415883, PMID 37309249, PMID 37310872, PMID 38224710, PMID 38310910, PMID 39324693, PMID 39330966, PMID 39970397, PMID 40388952, PMID 40413053, PMID 41544642, PMID 42086568, PMID 42643234

NIH funding

R21MH132436 (1)